Found 5 matching trials
Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors
PHASE1This is a single-group, open, dose escalation and expansion Phase I clinica...
Location
Beijing Cancer Hospital
Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma
PHASE1To explore the efficacy and safety of TQB2825 injection combined immunochem...
Location
The First Affiliated Hospital of Bengbu Medical College
Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies
PHASE1The aim of this study is to evaluate the pharmacokinetic characteristics, s...
Location
Beijing Cancer Hospital
Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma
PHASE3Evaluation of the efficacy and safety of TQB2825 injection compared to immu...
Location
Beijing Cancer Hospital
Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
PHASE2The purpose of this study is to assess the preliminary efficacy of TQB2825 ...
Location
The First Affiliated Hospital of Wannan Medical College